Skip to Content

Calvenza EHV

This page contains information on Calvenza EHV for veterinary use.
The information provided typically includes the following:
  • Calvenza EHV Indications
  • Warnings and cautions for Calvenza EHV
  • Direction and dosage information for Calvenza EHV

Calvenza EHV

This treatment applies to the following species:
Manufacturer: Boehringer Ingelheim

Equine Rhinopneumonitis Vaccine

Killed Virus

Calvenza EHV Indications

For the vaccination of healthy, susceptible horses 6 months of age or older, including pregnant mares, as an aid in the reduction of respiratory disease due to equine herpesvirus type 1 (EHV-1) and type 4 (EHV-4).

Contents: This product contains the antigen listed above.

Administration and Dosage: Shake well before use. Using aseptic technique, inoculate horses intramuscularly with a 2 mL dose. Administer a second 2 mL dose intramuscularly in 3-4 weeks using a different injection site. Administer a third 2 mL dose in 3-4 weeks by either the intramuscular or intranasal route. Revaccinate annually and prior to anticipated exposure, by either the intramuscular or intranasal route.

Cautions: Store at a temperature between 35-45°F (2-7°C). Protect from freezing. Use entire contents when first opened. Do not vaccinate within 21 days before slaughter. Anaphylactoid reactions may occur following use.

Antidote: Epinephrine.

Preservative: Gentamicin.

Precaution: This product has been tested under laboratory conditions and shown to meet all Federal standards for safety and efficacy in normal, healthy, immunocompetent animals. This level of performance may be affected by conditions such as stress, weather, nutrition, disease, parasitism, other treatments, individual idiosyncrasies or impaired immunological competency. These factors should be considered by the user when evaluating product performance or freedom from reactions.

For Veterinary Use Only

Boehringer Ingelheim Vetmedica, Inc., St. Joseph, MO 64506 U.S.A.

U.S. Veterinary License No. 124





10 - 1 dose/2 mL Syringes



10 Doses/20 mL


NAC No.: 10281263

Telephone:   800-325-9167
Fax:   816-236-2717
Every effort has been made to ensure the accuracy of the Calvenza EHV information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.

Copyright © 2018 North American Compendiums. Updated: 2018-08-01